New Enterprise Associates 14 L.P. 13D and 13G filings for Lumos Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-05 2:41 pm Sale | 2021-12-27 | 13D | Lumos Pharma, Inc. LUMO | New Enterprise Associates 14 L.P. | 0 0.000% | -524,030 (Position Closed) | Filing |
| 2020-03-31 5:48 pm Purchase | 2020-03-18 | 13D | Lumos Pharma, Inc. LUMO | New Enterprise Associates 14 L.P. | 524,030 6.300% | 524,030 (New Position) | Filing |